Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of Alendronate 70mg Formulation on Bone Turnover Markers and Patient Reported Outcomes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03435094
Recruitment Status : Unknown
Verified February 2018 by Labatec Pharma SA.
Recruitment status was:  Not yet recruiting
First Posted : February 15, 2018
Last Update Posted : February 23, 2018
Sponsor:
Information provided by (Responsible Party):
Labatec Pharma SA

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : August 1, 2019
Estimated Study Completion Date : August 1, 2019